WHO ICTRP trial

A clinical trial to study the efficacy and safety of Viracure cream in patients…

CTRI/2011/05/001706 · Clinical Trials Registry India (CTRI) · Not Recruiting

Key facts

Trial ID CTRI/2011/05/001706
Public title A clinical trial to study the efficacy and safety of Viracure cream in patients with Genital Herpes virus 2 infection.
Scientific title A Phase II, randomized, assessor-blind, placebo-controlled, multicenter, comparative, prospective study to assess the efficacy and safety of Viracure cream in immunocompetent patients with Genital Herpes due to Herpes Simplex Virus -2 infection.
Primary sponsor Piramal Life Sciences Limited
Registry Clinical Trials Registry India (CTRI)
Recruitment status Not Recruiting
Study type Interventional
Phase Phase 2
Countries India;India
Conditions Health Condition 1: null- genital herpes caused due to Herpes simplex virus 2
Interventions Intervention1: Viracure cream: Topical application thrice a day for 14 days Control Intervention1: Placebo cream: Topical application thrice a day for 14 days
Registration date Apr 5, 2011
Target size 136
Secondary IDs Viracure/54/10
Registry page ctri.nic.in

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations